XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 123 filers reported holding XENON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $375,760 | -11.3% | 11,000 | 0.0% | 0.14% | -7.2% |
Q2 2023 | $423,500 | +7.6% | 11,000 | 0.0% | 0.15% | -1.3% |
Q1 2023 | $393,690 | -9.2% | 11,000 | 0.0% | 0.15% | -14.4% |
Q4 2022 | $433,730 | +9.3% | 11,000 | 0.0% | 0.18% | +4.0% |
Q3 2022 | $397,000 | +18.5% | 11,000 | 0.0% | 0.17% | +29.1% |
Q2 2022 | $335,000 | -0.3% | 11,000 | 0.0% | 0.13% | +21.8% |
Q1 2022 | $336,000 | -2.3% | 11,000 | 0.0% | 0.11% | +4.8% |
Q4 2021 | $344,000 | +104.8% | 11,000 | 0.0% | 0.10% | +90.9% |
Q3 2021 | $168,000 | -18.0% | 11,000 | 0.0% | 0.06% | -16.7% |
Q2 2021 | $205,000 | +4.1% | 11,000 | 0.0% | 0.07% | -2.9% |
Q1 2021 | $197,000 | +16.6% | 11,000 | 0.0% | 0.07% | +7.9% |
Q4 2020 | $169,000 | +38.5% | 11,000 | 0.0% | 0.06% | +23.5% |
Q3 2020 | $122,000 | -11.6% | 11,000 | 0.0% | 0.05% | -19.0% |
Q2 2020 | $138,000 | +10.4% | 11,000 | 0.0% | 0.06% | -8.7% |
Q1 2020 | $125,000 | -13.2% | 11,000 | 0.0% | 0.07% | +15.0% |
Q4 2019 | $144,000 | +45.5% | 11,000 | 0.0% | 0.06% | +33.3% |
Q3 2019 | $99,000 | – | 11,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 467,368 | $7,188,000 | 3.91% |
Ghost Tree Capital, LLC | 700,000 | $10,766,000 | 2.40% |
BVF INC/IL | 3,499,346 | $53,820,000 | 2.12% |
DAFNA Capital Management LLC | 346,535 | $5,330,000 | 1.59% |
Parkman Healthcare Partners LLC | 361,689 | $5,563,000 | 1.42% |
KNOTT DAVID M | 200,000 | $3,076,000 | 1.39% |
Soleus Capital Management, L.P. | 558,117 | $8,584,000 | 1.13% |
Avoro Capital Advisors LLC | 2,800,000 | $43,064,000 | 0.74% |
NEA Management Company, LLC | 992,107 | $15,259,000 | 0.40% |
Orbimed Advisors | 2,497,917 | $38,418,000 | 0.34% |